The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.
Research into the endocannabinoid signaling system has grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Important advances have been made in our understanding of the endocannabinoid signaling system in various aspects of alcoholism, including alcohol-seeking behavior. Alcohol increases the synthesis or impairs the degradation of endocannabinoids, leading to a locally elevated endocannabinoid tone within the brain. Elevated endocannabinoid tone might be expected to result in compensatory down-regulation of CB1 receptors or dampened signal transduction. Following release, endocannabinoids diffuse back to the presynaptic neuron where they act as short-range modulators of synaptic activity by altering neurotransmitter release and synaptic plasticity. Mice treated with the CB1 receptor antagonist SR141716A (rimonabant) or homozygous for a deletion of the CB1 receptor gene exhibit reduced voluntary alcohol intake. CB1 knockout mice also show increased alcohol sensitivity, withdrawal, and reduced conditioned place preference. Conversely, activation of CB1 receptor promotes alcohol intake. Recent studies also suggest that elevated endocannabinoid tone due to impaired degradation contributes to high alcohol preference and self-administration. These effects are reversed by local administration of rimonabant, suggesting the participation of the endocannabinoid signaling system in high alcohol preference and self-administration. These recent advances will be reviewed with an emphasis on the endocannabinoid signaling system for possible therapeutic interventions of alcoholism.
Basavarajappa
Balapal S
BS
Division of Analytical Psychopharmacology, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. Basavaraj@nki.rfmh.org
D000437:Alcoholism / Q000188:drug therapy*; D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism*; D063388:Endocannabinoids; D006801:Humans; D051379:Mice; D043882:Receptors, Cannabinoid / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid
Proc Biol Sci. 1998 Nov 7;265(1410):2081-5
9842734
Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):235-42
12052039
Neuropsychopharmacology. 2007 Jan;32(1):117-26
16482090
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3662-5
11259648
J Neurosci. 2003 Mar 15;23(6):2453-8
12657705
Biochim Biophys Acta. 2000 Dec 15;1535(1):78-86
11113634
J Pharmacol Exp Ther. 2002 Jun;301(3):1020-4
12023533
Eur J Neurosci. 2001 Jul;14(2):342-52
11553284
Recept Channels. 1999;6(5):363-74
10551268
Prog Neurobiol. 2002 Apr;66(5):307-44
12015198
Behav Brain Res. 2005 Nov 7;164(2):206-13
16140402
Stroke. 2002 Aug;33(8):2112-4
12154273
Eur J Pharmacol. 2003 Apr 11;466(1-2):73-83
12679143
Neuropharmacology. 2004 Feb;46(2):243-53
14680762
Mol Psychiatry. 2004 Oct;9(10):916-31
15289816
Neurosci Lett. 2003 Jun 12;343(3):216-8
12770700
J Biol Chem. 1996 Nov 15;271(46):29468-72
8910614
Behav Pharmacol. 2002 Sep;13(5-6):451-63
12394421
Alcohol. 1984 Mar-Apr;1(2):133-40
6336143
Eur J Pharmacol. 1998 Jan 2;341(1):39-44
9489854
Annu Rev Neurosci. 1996;19:319-40
8833446
Chem Phys Lipids. 2000 Nov;108(1-2):123-34
11106786
Science. 2002 Apr 26;296(5568):678-82
11976437
J Neurosci Res. 2001 May 15;64(4):429-36
11340650
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8384-8
12060781
Science. 1997 Aug 22;277(5329):1094-7
9262477
Alcohol Res Health. 2002;26(3):193-201
12875047
Psychopharmacology (Berl). 1997 Jul;132(1):104-6
9272766
Zhongguo Yao Li Xue Bao. 1999 Dec;20(12):1109-14
11189201
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
10570211
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
2308954
J Neurosci. 2000 Jan 1;20(1):51-8
10627580
Nature. 1970 May 23;226(5247):701-4
5443246
Br J Pharmacol. 2004 Oct;143(4):455-64
15371286
Mol Pharmacol. 2000 Oct;58(4):814-20
10999952
Nature. 1996 Nov 7;384(6604):83-7
8900284
Science. 1996 Sep 20;273(5282):1719-22
8781236
Neuroscience. 2003;119(2):481-96
12770562
Eur J Biochem. 2001 Apr;268(7):1982-9
11277920
Neuroscience. 1998 Jul;85(2):395-403
9622239
J Neurochem. 1997 Aug;69(2):631-8
9231721
J Neurophysiol. 2001 Jul;86(1):40-8
11431486
Am J Pharmacogenomics. 2003;3(4):217-32
12930156
J Neurochem. 1999 Sep;73(3):1084-9
10461898
Brain Res. 2002 Nov 1;954(1):73-81
12393235
J Neurosci. 1999 Jun 1;19(11):4544-58
10341254
Crit Rev Neurobiol. 1999;13(3):243-81
10803637
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
2899326
Neuropharmacology. 2006 Jun;50(7):834-44
16448676
Nature. 1970 Sep 12;227(5263):1151-2
4915993
Prog Neurobiol. 1998 Nov;56(4):385-431
9775400
Biochem Pharmacol. 1998 Feb 15;55(4):515-21
9514087
J Neurosci. 1999 May 1;19(9):3277-86
10212287
Nature. 1997 Aug 21;388(6644):773-8
9285589
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:619-31
12432948
J Biol Chem. 1995 Jun 9;270(23):13973-80
7775459
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1221-47
15588749
Brain Res. 1998 Aug 17;802(1-2):19-26
9748483
Psychopharmacology (Berl). 1999 Mar;142(3):302-8
10208323
Neurosci Lett. 1993 Sep 3;159(1-2):83-7
7505417
Mol Pharmacol. 1994 Sep;46(3):516-22
7935333
Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):287-99
12052043
Biochem J. 1995 Dec 1;312 ( Pt 2):637-41
8526880
J Neurosci. 2004 Dec 8;24(49):11070-8
15590923
Chem Phys Lipids. 2000 Nov;108(1-2):53-70
11106782
Alcohol Clin Exp Res. 2005 Aug;29(8):1504-13
16156047
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11891-6
15280536
Chem Phys Lipids. 2000 Nov;108(1-2):107-21
11106785
J Pharmacol Exp Ther. 1993 Apr;265(1):218-26
8474008
Nature. 1993 Sep 2;365(6441):61-5
7689702
Br J Pharmacol. 1999 Jun;127(4):935-40
10433501
FASEB J. 2001 Feb;15(2):300-2
11156943
Neuropsychopharmacology. 2005 Feb;30(2):339-49
15383833
Neurosci Lett. 1998 Oct 2;254(3):137-40
10214976
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5802-7
10318965
Alcohol Alcohol. 1998 Mar-Apr;33(2):126-30
9566474
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):102S-109S
16344593
Nature. 1998 Dec 17;396(6712):636-7
9872309
Pharmacol Biochem Behav. 2005 Jun;81(2):263-84
15936806
Biochem Biophys Res Commun. 1999 Mar 16;256(2):377-80
10079192
Eur J Neurosci. 2005 Apr;21(8):2243-51
15869521
Neuroscience. 2002;113(3):671-82
12150787
J Biol Chem. 1998 Nov 27;273(48):32332-9
9822713
Biochem Pharmacol. 1995 Jun 29;50(1):83-90
7605349
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2105-8
3008152
J Neurochem. 2003 Feb;84(4):698-704
12562514
FEBS Lett. 1999 Apr 16;449(1):61-5
10225429
Mol Pharmacol. 2001 Jul;60(1):155-63
11408610
Am J Physiol. 1999 Jun;276(6):H2085-93
10362691
Science. 1992 Dec 18;258(5090):1946-9
1470919
Mol Pharmacol. 1998 Nov;54(5):834-43
9804618
Nat Neurosci. 2002 May;5(5):446-51
11976704
J Neural Transm (Vienna). 2000;107(6):613-38
10943904
Brain Res. 2001 Dec 7;921(1-2):240-55
11720732
Alcohol Clin Exp Res. 2002 Apr;26(4):565-74
11981134
Neuroscience. 2000;97(1):89-97
10771342
J Neurosci. 2001 Jan 1;21(1):109-16
11150326
Eur J Heart Fail. 2004 Jun;6(4):501-8
15182777
J Neurochem. 1999 Feb;72(2):522-8
9930723
Nature. 1994 Dec 15;372(6507):686-91
7990962
Alcohol Alcohol. 2004 Jul-Aug;39(4):297-302
15208160
FEBS Lett. 1995 Feb 13;359(2-3):133-6
7867785
Pharmacol Toxicol. 2001 Apr;88(4):213-22
11322181
Alcohol Clin Exp Res. 2001 Feb;25(2):277-82
11236843
Nat Neurosci. 1999 Apr;2(4):358-63
10204543
Alcohol Clin Exp Res. 2001 Sep;25(9):1317-23
11584151
Mol Pharmacol. 2001 Jun;59(6):1369-75
11353795
Brain Res. 1998 May 18;793(1-2):212-8
9630633
Eur J Pharmacol. 1999 Apr 16;370(3):233-40
10334497
Pharmacol Rev. 2002 Jun;54(2):161-202
12037135
Drug Alcohol Depend. 2002 Mar 1;66(1):77-84
11850139
Neurochem Int. 2006 Nov;49(6):619-25
16822589
J Neurosci. 2004 Jan 7;24(1):53-62
14715937
J Neurosci. 1991 Feb;11(2):563-83
1992016
Neuroreport. 2000 Apr 27;11(6):1231-5
10817598
Curr Opin Neurobiol. 1996 Apr;6(2):228-36
8725965
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1393-8
12538878
J Neurosci. 1997 Feb 15;17(4):1226-42
9006968
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3376-80
7724569
Alcohol Clin Exp Res. 1980 Jul;4(3):288-93
6996514
Nat Med. 2006 Jun;12(6):671-6
16715087
J Neurosci Res. 2000 Apr 1;60(1):122-8
10723075
Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97
7575630
Neuroreport. 1994 Jun 2;5(10):1265-8
7919180
Eur J Pharmacol. 1998 Oct 16;359(1):1-18
9831287
J Neurochem. 2000 Dec;75(6):2434-44
11080195
Trends Pharmacol Sci. 2003 Jun;24(6):266-8
12823949
Psychopharmacology (Berl). 2002 Jan;159(2):181-7
11862347
Alcohol Clin Exp Res. 1997 Oct;21(7):1199-203
9347079
Brain Res. 1999 Jan 2;815(1):89-97
9974126
Psychopharmacology (Berl). 2006 Jan;183(4):394-403
16261315
J Neurosci. 1997 May 15;17(10):3946-55
9133412
Learn Mem. 2000 May-Jun;7(3):132-9
10837502
Science. 1997 Jun 27;276(5321):2048-50
9197269
J Neurophysiol. 2001 Jan;85(1):468-71
11152748
J Pharmacol Exp Ther. 2001 Jul;298(1):7-14
11408519
J Biol Chem. 2001 Oct 12;276(41):38289-96
11468287
Physiol Rev. 1997 Jan;77(1):1-20
9016298
J Neurosci. 2002 May 1;22(9):3332-7
11978808
Eur J Pharmacol. 2002 May 17;443(1-3):95-7
12044797
Eur J Pharmacol. 2001 Nov 2;430(2-3):369-71
11711056
Biochem J. 2000 Apr 15;347(Pt 2):369-73
10749665
Arch Gen Psychiatry. 1983 Apr;40(4):435-42
6838323
Hypertension. 1999 Jan;33(1 Pt 2):429-34
9931142
J Biol Chem. 2001 Mar 9;276(10):6967-73
11118429
Lancet. 2005 Apr 16-22;365(9468):1389-97
15836887
Mol Pharmacol. 2005 Nov;68(5):1196-202
16051747
Life Sci. 1999;65(6-7):657-64
10462066
Psychol Rev. 1987 Oct;94(4):469-92
3317472
Biochem Pharmacol. 1994 Feb 11;47(4):711-5
8129747
Alcohol Alcohol. 2004 Mar-Apr;39(2):88-92
14998822
J Neurochem. 2006 Oct;99(1):308-20
16987253
Mol Pharmacol. 2000 Feb;57(2):288-95
10648638
J Neurophysiol. 2000 Jun;83(6):3287-93
10848548
Mamm Genome. 1998 Dec;9(12):927-8
9880654